Valora Therapeutics Inc.

About Valora Therapeutics Inc.

Valora Therapeutics is focused on transforming patient care through immunotherapy by harnessing the power of glycobiology. Their mission is to restore defective immune communication in diseases using their proprietary AbLec™ platform, which decodes the complex sugar code of cellular to immune interactions. They aim to make a meaningful difference in patients' lives through bold innovation and scientific curiosity.

Products & Services

AbLec™ Platform:A proprietary platform that decodes the sugar code of cellular to immune interactions to unlock new possibilities in immunotherapy.

Specialties

Immunotherapy Glycobiology

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed T: - FT: Seed	A: 30000000 MR: - FA: $30 Million FAN: 30000000	D: 2024-11-20 FD: 2024-11-20	5 investors

Seed Latest

2024-11-20

$30.0M

5 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

P

Plutarch

Greek Philosopher

C

Carolyn Bertozzi

Baker Family Director of Sarafan ChEM-H, Anne T. and Robert M. Bass Professor in the School of Humanities and Sciences and Professor, by courtesy, of Chemical and Systems Biology and of Radiology at Stanford University, and an Investigator of the Howard Hughes Medical Institute

J

Jessica Stark

Assistant Professor of Biological Engineering and Chemical Engineering

M

Miguel Garcia-Guzman

CEO

J

Jerry Fong

Sr. Director

B

Barbara Visentin

Director

View 16 more team members with Pro

Unlock Full Team Directory

Recent News